Stocks to watch: Mankind Pharma Limited has pledged 39.68 per cent of its equity stake in its fully-owned subsidiary Bharat Serums and Vaccines Limited to secure non-convertible debentures totalling ₹5,000 crores. Mankind Pharma's share price closed in green, up 2.68 per cent, at ₹2,600.00 on November 15 on BSE. Mankind Pharma, in an exchange filing, announced, “This is to inform …
Stock Market Today: Mankind Pharma share price opened 4.6% higher post to its announcements pertaining to acquisition of stakes in Bharat Serums and Vaccines Limited. Mankind Pharma announced having entered into a definitive agreement to acquire a 100% stake in Bharat Serums and Vaccines Limited from Advent International, one of the key private equity investors. Deal valuation Mankind Pharma said …
Mankind Pharma Ltd said it had entered into a definitive agreement to acquire a 100% stake in Bharat Serums and Vaccines Ltd from private equity firm Advent International for an enterprise value of about ₹13,630 crore subject to closing related adjustments. “This strategic move marks a significant leap for Mankind Pharma, positioning it as a market leader in the Indian …
Mankind Pharma is in talks with many private equity companies to form a joint bid to acquire Bharat Serums and Vaccines in a consortium, the Hindu BusinessLine reported, citing sources. Bain Capital, Blackstone, Carlyle, and KKR expressed interest in BSV after its current owner, Advent International, put it up for sale. While Mankind is in talks with these firms, the …